Jones Financial Companies
FOLD

Jones Financial Companies’s Amicus Therapeutics FOLD Stock Holding History

Jones Financial Companies’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.61K Buy
528
+250
+90% +$3.58K ﹤0.01% 3677
2025
Q4 		$3.96K Hold
278
– – ﹤0.01% 3592
2025
Q3 		$2.29K Hold
278
– – ﹤0.01% 3648
2025
Q2 		$1.65K Sell
278
-111
-29% -$716 ﹤0.01% 3532
2025
Q1 		$3.28K Buy
389
+8
+2% +$74 ﹤0.01% 3107
2024
Q4 		$3.59K Sell
381
-114
-23% -$1.19K ﹤0.01% 2854
2024
Q3 		$5.3K Buy
+495
New +$5.39K ﹤0.01% 2426

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jones Financial Companies's FOLD Position: Q1 2026 in Review

Jones Financial Companies increased its Amicus Therapeutics (FOLD) stake by 90% in Q1 2026, buying an estimated $3.58K and bringing the position to 528 shares worth $7.61K. The position accounts for ﹤0.01% of the portfolio, ranked #3677.

Jones Financial Companies first reported a position in FOLD in Q3 2024 and has held it in 7 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Jones Financial Companies held 528 shares of Amicus Therapeutics worth $7.61K as of Q1 2026.
  • Jones Financial Companies bought 250 Amicus Therapeutics shares in Q1 2026, an estimated $3.58K.
  • Amicus Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3677 holding.
  • Jones Financial Companies first reported a position in Amicus Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.